Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

ZFYVE26 Antikörper (C-Term)

Der Kaninchen Polyklonal Anti-ZFYVE26-Antikörper wurde für WB und EIA validiert. Er ist geeignet, ZFYVE26 in Proben von Human, Maus und Ratte zu detektieren.
Produktnummer ABIN783824

Kurzübersicht für ZFYVE26 Antikörper (C-Term) (ABIN783824)

Target

Alle ZFYVE26 Antikörper anzeigen
ZFYVE26 (Zinc Finger, FYVE Domain Containing 26 (ZFYVE26))

Reaktivität

  • 10
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Human, Maus, Ratte

Wirt

  • 10
Kaninchen

Klonalität

  • 10
Polyklonal

Konjugat

  • 6
  • 2
  • 1
  • 1
Dieser ZFYVE26 Antikörper ist unkonjugiert

Applikation

  • 6
  • 4
  • 2
  • 2
  • 2
Western Blotting (WB), Enzyme Immunoassay (EIA)
  • Bindungsspezifität

    • 5
    • 2
    • 1
    • 1
    • 1
    • 1
    C-Term

    Spezifität

    This antibody reacts to ZFYVE26.

    Aufreinigung

    Affinity chromatography

    Immunogen

    16 amino acid peptide near the carboxy terminus of human SPG15.
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1,0 mg/mL

    Buffer

    PBS containing 0.02 % sodium azide as preservative

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C

    Informationen zur Lagerung

    Store the antibody undiluted at 2-8 °C.
  • Target

    ZFYVE26 (Zinc Finger, FYVE Domain Containing 26 (ZFYVE26))

    Andere Bezeichnung

    ZFYVE26

    Hintergrund

    Hereditary spastic paraplegias (HSPs) are genetically and phenotypically heterogeneous disorders. Spastic paraplegia with thinning of the corpus callosum (ARHSP-TCC) is a relatively frequent form of complicated hereditary spastic paraplegia in which mental retardation and muscle stiffness at onset are followed by slowly progressive paraparesis and cognitive deterioration. SPG15 is the second gene known to be responsible for ARHSP-TCC in the Italian population. Mutations in this gene are associated with autosomal recessive spastic paraplegia-15. SPG15 encodes a protein containing a FYVE zinc finger binding domain which is thought to target these proteins to membrane lipids through interaction with phospholipids in the membrane. SPG15 mRNA is widely distributed in human tissues, as well as in rat embryos, suggesting a possible role for this protein during embryonic development. SPG15 co-localizes partially with endoplasmic reticulum and endosome markers, suggesting a role in intracellular trafficking. Multiple isoforms of SPG15 are known to exist.Synonyms: KIAA0321, Zinc finger FYVE domain-containing protein 26

    Gen-ID

    23503

    NCBI Accession

    NP_056161

    UniProt

    Q68DK2
Sie sind hier:
Chat with us!